Lipo Vela
Lipo Vela
Brand
Lipo Vela
Category
Lipolysis
Origin
Korea
Interested in ordering Lipo Vela? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Lipo Vela is a PPC/deoxycholate injectable lipolysis solution manufactured in South Korea by HJ Corporations Co., Ltd., intended for non-surgical body contouring and localized fat reduction. It combines phosphatidylcholine and sodium deoxycholate with L-carnitine and vitamins to support fat metabolism and skin condition. It is marketed for professional mesotherapy use.
How it works
Phosphatidylcholine and sodium deoxycholate disrupt adipocyte cell membranes, breaking down fat cells; the liberated lipids clear through the lymphatic system and are metabolized over several weeks. L-carnitine supports fatty-acid transport during this process. An inflammatory phase produces the expected swelling over the first 3-7 days.
Indications
- Abdomen
- Inner and outer thighs
- Flanks / love handles
- Upper arms
- Submental / double chin
Key features
- PPC plus sodium deoxycholate dual-lipolytic base
- Added L-carnitine and vitamins
- Body-contouring mesotherapy format
- Multi-vial packaging
- Manufactured by HJ Corporations Co., Ltd. (Korea)
Benefits
- Non-surgical option for stubborn localized fat
- Familiar PPC/deoxycholate mechanism for practitioners
- Staged protocol suits treatment-course pricing
- Broad body-area applicability
- Distributor-supported supply for enquiry-to-order
Composition
Phosphatidylcholine (PPC) and sodium deoxycholate with L-carnitine and vitamins (including riboflavin / B2)
Usage & handling
Inject subcutaneously into the mid-fat plane in a grid or fanning pattern with conservative per-point volumes, staging sessions about 3-4 weeks apart. Anticipate swelling, tenderness and bruising for 3-7 days. Avoid superficial or intramuscular placement and confirm regional anatomy before treating.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.